4//SEC Filing
Plinio Mark D. 4
Accession 0001694665-22-000132
CIK 0001694665other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:24 PM ET
Size
5.6 KB
Accession
0001694665-22-000132
Insider Transaction Report
Form 4
Plinio Mark D.
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-07-29$1.79/sh+1,250$2,238→ 2,500 total
Footnotes (3)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Evelo Biosciences, Inc. 2018 Employee Stock Purchase Plan (the "ESPP"), for the ESPP purchase period of February 1, 2022 through July 31, 2022. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934.
- [F2]The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of July 29, 2022.
- [F3]In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of common stock on the Purchase Date of July 29, 2022.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001865558
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 4:24 PM ET
- Size
- 5.6 KB